LINC00106

Across TCGA pan-cancer cohorts, LINC00106 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated LINC00106 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher LINC00106 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC00106 expression acts as an unfavorable survival marker, although some lineages such as STAD and BLCA show a favorable association.

KIRC, STAD, and BLCA are the cancer types where LINC00106 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	All	0.505	0.695	<.001	91	view →
STAD	OS	Median	All	0.759	0.614	<.001	59	view →
BLCA	OS	Quartile	All	0.704	0.479	<.001	45	view →
READ	OS	Median	II,III,IV	0.791	0.296	<.001	40	view →
COAD	DFS	Median	III,IV	0.474	0.766	.002	36	view →
MESO	DFS	Median	II,III,IV	0.234	0.667	.001	27	view →
PRAD	DFS	Median	All	0.828	0.933	<.001	26	view →
LGG	DFS	Tertile	All	0.763	0.883	<.001	25	view →
SKCM	OS	Quartile	III,IV	0.690	0.263	.003	22	view →
PAAD	OS	Median	II,III,IV	0.722	0.518	.021	13	view →
UCS	DFS	Tertile	IV	0.956	0.312	.024	12	view →
THYM	DFS	Median	III,IV	1.000	0.463	.007	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

LINC00106–KIRC (DFS)

Open the KIRC breakdown →